22 Dec Dipeptidyl peptidase-4 inhibitors and the incidence of inflammatory bowel disease among patients with type 2 diabetes
Posted at 11:54h
in
Abrahami D, Douros A, Yin H, Renoux C, Yu OHY, Bitton A, Azoulay L. Dipeptidyl peptidase-4 inhibitors and the incidence of inflammatory bowel disease among patients with type 2 diabetes. BMJ. 2018 Mar; 21;360:k872.